A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

M Kanai, K Yoshimura, M Asada, A Imaizumi… - Cancer chemotherapy …, 2011 - Springer
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

[PDF][PDF] A Phase I/II Study of Complementary Therapy Using Curcumin for Patients with Gemcitabine-Resistant Pancreatic Cancer

M Kanai, K Yoshimura, M Asada, A Imaizumi, C Suzuki… - core.ac.uk
Purpose: Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

M Kanai, K Yoshimura, M Asada… - Cancer …, 2011 - search.proquest.com
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with
gemcitabine-resistant pancreatic cancer Page 1 ORIGINAL ARTICLE A phase I/II study of …

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

M Kanai, K Yoshimura, M Asada… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

[PDF][PDF] A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

M Kanai, K Yoshimura, M Asada, A Imaizumi… - Cancer Chemother …, 2011 - greenwood.ru
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

[HTML][HTML] A Phase I/II Study of Gemcitabine-Based Chemotherapy Plus Curcumin for Patients with Gemcitabine-Resistant Pancreatic Cancer

P Ayurveda - Cancer Chemotherapy and Pharmacology, 2011 - planetayurveda.com
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer.

M Kanai, K Yoshimura, M Asada… - Cancer …, 2011 - repository.kulib.kyoto-u.ac.jp
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

[引用][C] A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

M KANAI, K YOSHIMURA… - Cancer …, 2011 - pascal-francis.inist.fr
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with
gemcitabine-resistant pancreatic cancer CNRS Inist Pascal-Francis CNRS Pascal and …

[PDF][PDF] A Phase I/II Study of Complementary Therapy Using Curcumin for Patients with Gemcitabine-Resistant Pancreatic Cancer

M Kanai, K Yoshimura, M Asada, A Imaizumi, C Suzuki… - researchgate.net
Purpose: Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer.

金井 - Cancer chemotherapy and pharmacology, 2011 - cir.nii.ac.jp
Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …